Literature DB >> 24798834

Telemedicine in COPD: time to pause.

Roger S Goldstein1, Sachi O'Hoski2.   

Abstract

There is increasing interest in the use of telemedicine to assist in the management of chronic diseases. Telemedicine possibilities for patients with COPD include medical consultations, in-home patient monitoring, and remote rehabilitation. Teleconsultations have been used successfully, saving time and travel costs for patients with only a few subsequently requiring face-to-face visits. Despite many reports, the impact of telemonitoring on the detection of exacerbations, reductions in health-care utilization, and cost savings is equivocal. Given the health-care costs and commitment involved in telemonitoring, well-designed longer-term multicenter studies with appropriate follow-up are required prior to its more widespread application. Emerging evidence from preliminary trials of telerehabilitation for the pulmonary patient is encouraging. It may represent a useful tool for increasing access and building capacity, especially in remote areas.

Entities:  

Mesh:

Year:  2014        PMID: 24798834     DOI: 10.1378/chest.13-1656

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study.

Authors:  Daniel Sanchez-Morillo; Miguel Angel Fernandez-Granero; Antonio León Jiménez
Journal:  Med Biol Eng Comput       Date:  2015-03-01       Impact factor: 2.602

2.  Clinician's Commentary on Chan et al.1.

Authors:  Virginia Huynh; Michael Stickland
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

3.  A Telemedicine-Based Intervention Reduces the Frequency and Severity of COPD Exacerbation Symptoms: A Randomized, Controlled Trial.

Authors:  Francis C Cordova; David Ciccolella; Carla Grabianowski; John Gaughan; Kathleen Brennan; Frederick Goldstein; Michael R Jacobs; Gerard J Criner
Journal:  Telemed J E Health       Date:  2015-08-10       Impact factor: 3.536

4.  Computer-Mediated Experiences of Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Samantha R Paige; Michael Stellefson; Janice L Krieger; Julia M Alber
Journal:  Am J Health Educ       Date:  2019-02-26

Review 5.  Defining and targeting health disparities in chronic obstructive pulmonary disease.

Authors:  Roy A Pleasants; Isaretta L Riley; David M Mannino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-04

6.  Subgroup analysis of telehealthcare for patients with chronic obstructive pulmonary disease: the cluster-randomized Danish Telecare North Trial.

Authors:  Flemming Witt Udsen; Pernille H Lilholt; Ole K Hejlesen; Lars H Ehlers
Journal:  Clinicoecon Outcomes Res       Date:  2017-07-07

7.  Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.

Authors:  Andrew Farmer; Veronika Williams; Carmelo Velardo; Syed Ahmar Shah; Ly-Mee Yu; Heather Rutter; Louise Jones; Nicola Williams; Carl Heneghan; Jonathan Price; Maxine Hardinge; Lionel Tarassenko
Journal:  J Med Internet Res       Date:  2017-05-03       Impact factor: 5.428

8.  Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.

Authors:  Thomas Ringbæk; Allan Green; Lars Christian Laursen; Ejvind Frausing; Eva Brøndum; Charlotte Suppli Ulrik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-03

Review 9.  Physiological basis of cardiopulmonary rehabilitation in patients with lung or heart disease.

Authors:  Zafeiris Louvaris; Ioannis Vogiatzis
Journal:  Breathe (Sheff)       Date:  2015-06

10.  Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.

Authors:  Flemming Witt Udsen; Pernille Heyckendorff Lilholt; Ole Hejlesen; Lars Ehlers
Journal:  BMJ Open       Date:  2017-05-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.